Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Bommel

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
The Annals of Thoracic Surgery|December 22, 2010
Three-dimensional echocardiography for the preoperative assessment of patients with left ventricular aneurysmNina Ajmone Marsan, Jos J M Westenberg, Stijntje D Roes, et al.
International Journal of Cardiology|April 8, 2017
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry)Miguel E Lemmert, Nicolas M van Mieghem, Robert-Jan van Geuns, et al.
Heart (British Cardiac Society)|April 14, 2009
Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapyQ Zhang, R J van Bommel, J W-H Fung, et al.
American Heart Journal|August 3, 2020
Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trialWijnand K den Dekker, Nicolas M Van Mieghem, Johan Bennett, et al.
Heart (British Cardiac Society)|July 9, 2010
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECTR J van Bommel, J Gorcsan, E S Chung, et al.
American Heart Journal|March 12, 2011
Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapyMiriam Shanks, Victoria Delgado, Arnold C T Ng, et al.
BMC Medicine|October 2, 2023
Return to work and health-related quality of life up to 1 year in patients hospitalized for COVID-19: the CO-FLOW studyL M Bek, J C Berentschot, M E Hellemons, et al.
Journal of the American College of Cardiology|October 30, 2010
Effect of biventricular pacing on diastolic dyssynchronyMiriam Shanks, Matteo Bertini, Victoria Delgado, et al.
Journal of the American College of Cardiology|September 26, 2009
Effects of cardiac resynchronization therapy on left ventricular twistMatteo Bertini, Nina Ajmone Marsan, Victoria Delgado, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapyMark M Boogers, Serge D Van Kriekinge, Maureen M Henneman, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
The Annals of Thoracic Surgery|December 22, 2010
Three-dimensional echocardiography for the preoperative assessment of patients with left ventricular aneurysmNina Ajmone Marsan, Jos J M Westenberg, Stijntje D Roes, et al.
International Journal of Cardiology|April 8, 2017
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry)Miguel E Lemmert, Nicolas M van Mieghem, Robert-Jan van Geuns, et al.
Heart (British Cardiac Society)|April 14, 2009
Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapyQ Zhang, R J van Bommel, J W-H Fung, et al.
American Heart Journal|August 3, 2020
Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trialWijnand K den Dekker, Nicolas M Van Mieghem, Johan Bennett, et al.
Heart (British Cardiac Society)|July 9, 2010
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECTR J van Bommel, J Gorcsan, E S Chung, et al.
American Heart Journal|March 12, 2011
Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapyMiriam Shanks, Victoria Delgado, Arnold C T Ng, et al.
BMC Medicine|October 2, 2023
Return to work and health-related quality of life up to 1 year in patients hospitalized for COVID-19: the CO-FLOW studyL M Bek, J C Berentschot, M E Hellemons, et al.
Journal of the American College of Cardiology|October 30, 2010
Effect of biventricular pacing on diastolic dyssynchronyMiriam Shanks, Matteo Bertini, Victoria Delgado, et al.
Journal of the American College of Cardiology|September 26, 2009
Effects of cardiac resynchronization therapy on left ventricular twistMatteo Bertini, Nina Ajmone Marsan, Victoria Delgado, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapyMark M Boogers, Serge D Van Kriekinge, Maureen M Henneman, et al.
Pageof 10